Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism
Clinical trial NCT02675530 · COMPLETED
Trial details
- NCT number
- NCT02675530
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2011-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.